Rep. Ilhan Omar Says Members of Congress Smoke Cannabis — Why It Matters

In a moment of blunt candor that ricocheted across social media, Rep. Ilhan Omar (D-MN) declared during a May 2026 interview that "there are a lot of people who smoke cannabis in Congress." She quickly added the caveat that "advocacy for legalizing doesn't necessarily mean that you are a user" — but the damage, or depending on your perspective, the honesty, was already in the public record.

The comment arrived during a week when the House was simultaneously voting on an amendment to allow VA doctors to recommend medical cannabis to veterans and debating appropriations language that would direct the DEA and FDA to crack down on unregulated cannabinoid products. The juxtaposition was not lost on observers: Congress was, in the same legislative session, expanding cannabis access for some Americans while restricting it for others — all while its own members were, according to Omar, partaking behind closed doors.

An Open Secret Becomes a Public Statement

Omar's remark did not reveal anything that Washington insiders did not already know. Anonymous surveys, off-the-record conversations with staffers, and the occasional public admission have long suggested that cannabis use on Capitol Hill mirrors or exceeds national averages. A 2024 Gallup poll found that 17 percent of American adults reported current cannabis use — a figure that represents a historic high in polling data.

What made Omar's statement newsworthy was not its content but its source: a sitting member of Congress speaking publicly and matter-of-factly about colleagues' cannabis consumption. In a political culture where cannabis policy votes still generate intense debate, the gap between private behavior and public positioning is rarely acknowledged so directly.

The history of politicians being caught or confessing cannabis use is long and bipartisan. Barack Obama wrote openly about marijuana use in his memoir. Bill Clinton's infamous "didn't inhale" line became a cultural touchstone. George W. Bush was recorded in private conversations acknowledging past use. More recently, Vice President Kamala Harris laughed about smoking in college during a 2019 radio interview.

But these admissions have always been framed in the past tense — youthful indiscretions safely distanced from the responsibilities of office. Omar's comment was different because it described present-tense behavior by current lawmakers.

The Hypocrisy Problem

The political mathematics of cannabis hypocrisy are striking. Cannabis remains federally illegal for recreational use under Schedule I of the Controlled Substances Act — the same classification as heroin. While the Justice Department's April 2026 order moved certain state-licensed medical cannabis products to Schedule III, recreational use remains a federal crime carrying potential penalties of up to one year imprisonment for simple possession.

This means that any member of Congress who uses recreational cannabis is committing a federal offense — an offense that their own institution has the power to change but has repeatedly declined to address comprehensively.

Meanwhile, the human cost of cannabis enforcement continues to accumulate, even as overall arrest numbers decline. FBI Uniform Crime Report data shows that cannabis arrests still number in the hundreds of thousands annually, disproportionately affecting Black and Latino communities. A Congress member who smokes cannabis in their Georgetown townhouse faces effectively zero risk of prosecution. A young Black man doing the same in the same city faces a fundamentally different risk calculus.

This is the hypocrisy that Omar's comment laid bare — not that politicians use cannabis, but that they do so while maintaining a legal framework that punishes millions of their constituents for identical behavior.

The Legislative Context

Omar's remarks landed during a particularly active week for cannabis legislation. The House voted 290 to 116 to pass an amendment allowing Department of Veterans Affairs doctors to recommend medical cannabis to veterans — a landmark bipartisan vote that reflected the overwhelming popular support for medical access.

At the same time, the House Appropriations Committee released draft report language directing the DEA and FDA to crack down on unregulated cannabinoid products flowing through the hemp market. The push to regulate delta-8 THC, HHC, and other intoxicating hemp derivatives reflects legitimate safety concerns, but critics argue it also protects the licensed cannabis industry from competition.

Georgia Governor Brian Kemp signed a bill expanding medical cannabis access, adding qualifying conditions and allowing vaping. Iowa doubled its medical cannabis dispensary count. California passed drive-through dispensary legislation. The VA amendment passed with strong bipartisan support.

These developments show that cannabis reform is happening — but incrementally, inconsistently, and always short of the comprehensive federal legalization that public polling consistently supports. According to Gallup, 70 percent of Americans favor full legalization, a number that has remained stable since 2022.

Why the Silence Persists

If members of Congress use cannabis and a supermajority of their constituents support legalization, why has comprehensive reform stalled for decades?

The answer involves a familiar stew of political incentives. Cannabis legalization does not neatly align with either party's coalition. Republicans face resistance from social conservatives and law enforcement groups. Democrats face pressure from public health advocates concerned about commercialization and from social equity constituencies who worry that corporate legalization will bypass the communities most harmed by prohibition.

The result is a political no-man's-land where incremental measures — a VA amendment here, a medical expansion there — can pass while comprehensive reform remains stuck. Individual members can support specific cannabis provisions without taking the political risk of championing full legalization.

Omar's comment disrupts this careful choreography by highlighting the absurdity of the status quo. It is hard to maintain the fiction that cannabis is a serious policy question requiring cautious deliberation when the deliberators themselves are among the consumers.

What Happens Next

Omar's statement is unlikely to produce an immediate policy shift. But it contributes to a slow erosion of the political stigma that has kept comprehensive reform off the legislative calendar.

The June 29 DEA hearing on broader Schedule III rescheduling will be the next major inflection point. If the hearing results in full rescheduling for all cannabis — including recreational products — it would represent the most significant federal policy change since the Controlled Substances Act was enacted in 1970. But rescheduling is not legalization. Cannabis would remain a controlled substance, and the gap between federal and state policy would persist.

For now, Omar's comment serves as a reminder that the people writing America's drug laws are not operating from a position of abstinence. They are participants in the same cannabis culture they regulate — a fact that should inform how seriously we take their objections to reform.

The question is not whether members of Congress smoke weed. It is whether they will ever let that private behavior inform their public votes.

Find a dispensary on Budpedia

Need a shop near you? Find a dispensary near you on Budpedia — filter by city, state, hours, and verified menu.